- New research and lab studies are providing more hope for the Pfizer vaccine.
- While Pfizer’s own study has shown that the vaccine can be stored in warmer temperatures now, a lab study has shown its effectiveness in new variants.
- Lab studies show the vaccine can neutralise two-third of the south African Variant.
- Pfizer has said there’s no real life report of new variants escaping the vaccine.
- Meanwhile Pfizer provided data that shows the vaccine can be stored at -70 ° instead of -112°